Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

617 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.
Grebely J, Dalgard O, Conway B, Cunningham EB, Bruggmann P, Hajarizadeh B, Amin J, Bruneau J, Hellard M, Litwin AH, Marks P, Quiene S, Siriragavan S, Applegate TL, Swan T, Byrne J, Lacalamita M, Dunlop A, Matthews GV, Powis J, Shaw D, Thurnheer MC, Weltman M, Kronborg I, Cooper C, Feld JJ, Fraser C, Dillon JF, Read P, Gane E, Dore GJ; SIMPLIFY Study Group. Grebely J, et al. Among authors: hellard m. Lancet Gastroenterol Hepatol. 2018 Mar;3(3):153-161. doi: 10.1016/S2468-1253(17)30404-1. Epub 2018 Jan 6. Lancet Gastroenterol Hepatol. 2018. PMID: 29310928 Free article. Clinical Trial.
Indications of immune protection from hepatitis C infection.
Aitken CK, Bowden S, Hellard M, Crofts N. Aitken CK, et al. Among authors: hellard m. J Urban Health. 2004 Mar;81(1):58-60. doi: 10.1093/jurban/jth088. J Urban Health. 2004. PMID: 15047784 Free PMC article.
Change in hepatitis C virus genotype in injecting drug users.
Aitken C, McCaw R, Jardine D, Bowden S, Higgs P, Nguyen O, Crofts N, Hellard M. Aitken C, et al. Among authors: hellard m. J Med Virol. 2004 Dec;74(4):543-5. doi: 10.1002/jmv.20212. J Med Virol. 2004. PMID: 15484265
Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C.
Matthews GV, Hellard M, Haber P, Yeung B, Marks P, Baker D, McCaughan G, Sasadeusz J, White P, Rawlinson W, Lloyd A, Kaldor J, Dore GJ; Australian Trial in Acute Hepatitis C Study Group. Matthews GV, et al. Among authors: hellard m. Clin Infect Dis. 2009 Mar 1;48(5):650-8. doi: 10.1086/596770. Clin Infect Dis. 2009. PMID: 19191653 Free PMC article.
Effective treatment of injecting drug users with recently acquired hepatitis C virus infection.
Dore GJ, Hellard M, Matthews GV, Grebely J, Haber PS, Petoumenos K, Yeung B, Marks P, van Beek I, McCaughan G, White P, French R, Rawlinson W, Lloyd AR, Kaldor JM; Australian Trial In Acute Hepatitis C Study Group. Dore GJ, et al. Among authors: hellard m. Gastroenterology. 2010 Jan;138(1):123-35.e1-2. doi: 10.1053/j.gastro.2009.09.019. Epub 2009 Sep 24. Gastroenterology. 2010. PMID: 19782085 Free PMC article.
Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study.
Grebely J, Petoumenos K, Matthews GV, Haber P, Marks P, Lloyd AR, Kaldor JM, Dore GJ, Hellard M; ATAHC Study Group. Grebely J, et al. Among authors: hellard m. Drug Alcohol Depend. 2010 Mar 1;107(2-3):244-9. doi: 10.1016/j.drugalcdep.2009.09.015. Drug Alcohol Depend. 2010. PMID: 19926405 Free PMC article. Clinical Trial.
617 results